Skip to main content
Adrienne Boire, MD, Neurology, New York, NY, Memorial Sloan Kettering Cancer Center

AdrienneABoireMDPhD

Neurology • New York, NY

Neurooncology

Associate Attending Neurologist; Associate Member, HOPP; Member, Brain Tumor Center

Request Appointment

Overview of Dr. Boire

Dr. Adrienne Boire is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 9 years. She is one of 57 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 70 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2012 - 2014
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2009 - 2012
  • University of Chicago
    University of ChicagoInternship, Internal Medicine, 2008 - 2009
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008
  • Tufts University School of Medicine
    Tufts University School of MedicinePh.D., Biochemistry, 2004
  • Macalester College
    Macalester CollegeB.A., Biology, Cum Laude, 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2026
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • IL State Medical License
    IL State Medical License 2008 - 2009
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Simches Young Investigator in Neuro-Oncology Award 2017
  • Vienna Medical Academy Award 2017
  • Damon Runyon Clinical Investigator Award 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis  
    Morikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E and AD Seidman, Clin Breast Cancer, 1/1/2016
  • Evaluating Cancer of the Central Nervous System through Next-Generation Sequencing of Cerebrospinal Fluid  
    Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M,..., J Clin Oncol, 1/1/2016
  • Molecular interactions in the development and treatment of brain metastases  
    Martinez NM, Boire A and LM DeAngelis, Int J Mol Sci, 1/1/2013
  • Join now to see all

Lectures

  • Targeting carcinoma-astrocyte gap junctions in brain metastasis. 
    Boston, MA - 1/25/2017
  • Microenvironmental contributions to CNS metastasis. 
    Marseille, France - 1/7/2017
  • Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. 
    Zurich, Switzerland - 1/5/2017
  • Join now to see all

Press Mentions

  • MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award Winners
    MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award WinnersMay 19th, 2023
  • Markers of Inflammation and Neurodegeneration in CSF Linked to Severe Symptoms in Hospitalized COVID-19 Patients
    Markers of Inflammation and Neurodegeneration in CSF Linked to Severe Symptoms in Hospitalized COVID-19 PatientsMarch 18th, 2021
  • Scientists Zeroing in on the Cause of 'COVID Brain'
    Scientists Zeroing in on the Cause of 'COVID Brain'March 5th, 2021
  • Join now to see all

Hospital Affiliations

Dr. Adrienne Boire, Dr. Adrienne Boire, MD, Dr. A Boire, Dr. Adrienne A Boire